- Home
- Publications
- Publication Search
- Publication Details
Title
Immune Therapy for Ovarian Cancer: Promise and Pitfalls
Authors
Keywords
-
Journal
INTERNATIONAL REVIEWS OF IMMUNOLOGY
Volume 30, Issue 2-3, Pages 102-119
Publisher
Informa UK Limited
Online
2011-05-11
DOI
10.3109/08830185.2011.567361
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukin 2 in Cancer Therapy
- (2012) G. K. Antony et al. CURRENT MEDICINAL CHEMISTRY
- Abagovomab for ovarian cancer
- (2011) Jacobus Pfisterer et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Assessing oncologic benefit in clinical trials of immunotherapy agents
- (2010) R. K. Hales et al. ANNALS OF ONCOLOGY
- Direct and indirect antitumor effects by human peripheral blood lymphocytes expressing both chimeric immune receptor and interleukin-2 in ovarian cancer xenograft model
- (2010) J M Lee et al. CANCER GENE THERAPY
- Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers
- (2010) Melissa A. Geller et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- In vitro metastatic colonization of human ovarian cancer cells to the omentum
- (2010) Shaheena M. Khan et al. CLINICAL & EXPERIMENTAL METASTASIS
- Natural immunity to cancer in humans
- (2010) Gabriela Bindea et al. CURRENT OPINION IN IMMUNOLOGY
- A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
- (2010) Melissa A. Geller et al. CYTOTHERAPY
- CD4+ T Cells Elicit Host Immune Responses to MHC Class II- Ovarian Cancer through CCL5 Secretion and CD40-Mediated Licensing of Dendritic Cells
- (2010) Y. C. Nesbeth et al. JOURNAL OF IMMUNOLOGY
- Antigen-Specific Immunity and Cross-Priming by Epithelial Ovarian Carcinoma-Induced CD11b+Gr-1+ Cells
- (2010) K. Tomihara et al. JOURNAL OF IMMUNOLOGY
- B7-H1-Dependent Sex-Related Differences in Tumor Immunity and Immunotherapy Responses
- (2010) P.-Y. Lin et al. JOURNAL OF IMMUNOLOGY
- A Phase I Trial of Repeated Intrapleural Adenoviral-mediated Interferon-β Gene Transfer for Mesothelioma and Metastatic Pleural Effusions
- (2010) Daniel H Sterman et al. MOLECULAR THERAPY
- Enhancing the Therapeutic Effect Against Ovarian Cancer Through a Combination of Viral Oncolysis and Antigen-specific Immunotherapy
- (2010) Yu-Qian Zhang et al. MOLECULAR THERAPY
- CD95 promotes tumour growth
- (2010) Lina Chen et al. NATURE
- High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma
- (2009) W-F Cheng et al. BRITISH JOURNAL OF CANCER
- Dissemination of intraperitoneal ovarian cancer: Discussion of mechanisms and demonstration of lymphatic spreading in ovarian cancer model
- (2009) Anis Feki et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Invariant NKT cells and CD1d+cells amass in human omentum and are depleted in patients with cancer and obesity
- (2009) Lydia Lynch et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Maintenance immunotherapy in recurrent ovarian cancer: Long term follow-up of a phase II study
- (2009) Francesco Recchia et al. GYNECOLOGIC ONCOLOGY
- The emergence of immunomodulation: Combinatorial immunochemotherapy opportunities for the next decade
- (2009) Lana E. Kandalaft et al. GYNECOLOGIC ONCOLOGY
- Omental Milky Spots Develop in the Absence of Lymphoid Tissue-Inducer Cells and Support B and T Cell Responses to Peritoneal Antigens
- (2009) Javier Rangel-Moreno et al. IMMUNITY
- Complete remission of ovarian cancer induced intractable malignant ascites with intraperitoneal bevacizumab. Immunological observations and a literature review
- (2009) Filippo Bellati et al. INVESTIGATIONAL NEW DRUGS
- Intra-abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer
- (2009) Jalid Sehouli et al. JOURNAL OF SURGICAL ONCOLOGY
- The Side Population of Ovarian Cancer Cells Is a Primary Target of IFN- Antitumor Effects
- (2008) L. Moserle et al. CANCER RESEARCH
- Safety and Immunogenicity Study of NY-ESO-1b Peptide and Montanide ISA-51 Vaccination of Patients with Epithelial Ovarian Cancer in High-Risk First Remission
- (2008) C. S.M. Diefenbach et al. CLINICAL CANCER RESEARCH
- Regulatory T cells and treatment of cancer
- (2008) Tyler J Curiel CURRENT OPINION IN IMMUNOLOGY
- Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways
- (2008) Brian T. Fife et al. IMMUNOLOGICAL REVIEWS
- Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
- (2008) F. S. Hodi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started